NeoPharm CO., LTD. (KOSDAQ:092730)
18,100
-260 (-1.42%)
May 20, 2026, 3:30 PM KST
36.30% (1Y)
| Market Cap | 283.11B +39.1% |
| Revenue (ttm) | 132.18B +11.1% |
| Net Income | 27.82B +20.6% |
| EPS | 1,778.81 +20.6% |
| Shares Out | 15.64M |
| PE Ratio | 10.18 |
| Forward PE | 8.74 |
| Dividend | 750.00 (3.91%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 51,951 |
| Average Volume | 74,584 |
| Open | 18,600 |
| Previous Close | 18,360 |
| Day's Range | 17,730 - 18,610 |
| 52-Week Range | 13,080 - 22,650 |
| Beta | n/a |
| RSI | 41.39 |
| Earnings Date | Aug 13, 2026 |